Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

82.76
+0.13000.16%
Volume:1.02M
Turnover:84.40M
Market Cap:11.66B
PE:-36.24
High:83.38
Open:81.58
Low:80.33
Close:82.63
52wk High:95.49
52wk Low:28.12
Shares:140.86M
Float Shares:122.00M
Volume Ratio:0.57
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:25.04
PE(LYR):-6,787.50

Loading ...

Arrowhead Pharmaceuticals To Rally Over 44%? Here Are 10 Top Analyst Forecasts For Tuesday

Benzinga_recent_news
·
Apr 21

Arrowhead Pharmaceuticals Raised to Overweight From Equal-Weight by Morgan Stanley

Dow Jones
·
Apr 21

Arrowhead Pharmaceuticals Inc : Morgan Stanley Raises to Overweight From Equal-Weight

THOMSON REUTERS
·
Apr 21

Arrowhead Pharmaceuticals Inc : Morgan Stanley Raises Target Price to $100.00 From $78.00

THOMSON REUTERS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Apr 21

Arrowhead upgraded to Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Apr 21

U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis

Reuters
·
Apr 21

Press Release: Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results

Dow Jones
·
Apr 21

Arrowhead price target raised to $93 from $81 at BofA

TIPRANKS
·
Apr 20

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

Arrowhead Pharmaceuticals : Bofa Global Research Raises Price Objective to $93 From $81

THOMSON REUTERS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20

Arrowhead Pharmaceuticals (ARWR) Is Up 5.9% After Durable Two-Year Plozasiran Data in Severe Hypertriglyceridemia

Simply Wall St.
·
Apr 06

Arrowhead presents long-term efficacy, safety data for plozasiran

TIPRANKS
·
Mar 30

Arrowhead says plozasiran cuts triglycerides up to 83% in two-year extension study

Reuters
·
Mar 28

J&J Exits 3 Biotechs, Retains Stakes in 2 Possible Acquisitions -- Barron's

Dow Jones
·
Mar 28

Analysts Conflicted on These Healthcare Names: Cibus (CBUS), Arrowhead Pharmaceuticals (ARWR) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Mar 26

Arrowhead Pharmaceuticals Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 26

A Look At Arrowhead Pharmaceuticals (ARWR) Valuation As Fisher Builds Stake And SHASTA Readouts Approach

Simply Wall St.
·
Mar 19